• The 4th annual E-Cigarette Summit will take place on Thursday 17th November at The Royal Society, London
  • Registration for the E-Cigarette Summit 2016 is now open

Dr Konstantinos Farsalinos M.D

Research Fellow
Onassis Cardiac Surgery Greece, Department of Pharmacology, University of Patras, Greece

Konstantinos E. Farsalinos, M.D., is a research fellow at the Onassis Cardiac Surgery Center in Athens, Greece, and at the Department of Pharmacy, University of Patras, Greece. He has been conducting laboratory and clinical research on e-cigarettes as principle investigator since 2011. Examples of his work include the first study on the cytotoxic effects of e-cigarette vapor on cultured cells and the immediate effects of e-cigarette use on cardiac function and coronary circulation. He ran a worldwide online survey of almost 20,000 vapers (users of e-cigarettes) identifying patterns of use and experience with e-cigarettes among consumers, published in 2014. He has presented his research findings at major international scientific congresses and his research was used in preparing the regulatory framework on e-cigarettes by the European Union. As of 2016, he has published more than 40 studies and articles in international peer-reviewed scientific journals about smoking, tobacco harm reduction, and e-cigarettes

Competing Interest: For some of the studies, the institution has received funding from e-cigarette companies. None of the researchers received any compensation for participating to the studies.

Dr Konstantinos Farsalinos M.D will be speaking at:

Panel Discussion and Q&A : How should the relative and absolute risks of e-cigarettes be communicated?

- 12:35 - 12:55

Absolute risk from e-vapour products for users and bystanders

- 11:55 - 12:15

« Back to previous page